Remove 2022 Remove Competition Remove Healthcare Provider
article thumbnail

Patent expiration to drive biosimilars market expansion to 2032

European Pharmaceutical Review

As of September 2022, there were around 39 biosimilars approved and 22 marketed, the report stated. This has resulted in “increased competition and price pressure, driving the growth of the biosimilar market”. The latter of which is important in “gaining a competitive advantage”, the author noted. million by 2032, at 17.6

Marketing 105
article thumbnail

Three Strategies to Optimize Healthcare Provider Networks in New and Existing Markets

Clarify Health

Here are our top three provider network optimization strategies for health plans seeking to gain market share and manage claims spend in 2023 and beyond. Use healthcare provider data to boost network performance Assessing provider performance is one of the key challenges of network design and optimization.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Nine for 2023, part three: thriving or surviving?

pharmaphorum

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

article thumbnail

9 Healthcare Marketing Trends to Embrace in 2023

Healthcare Success

In this blog, I share nine healthcare marketing trends you need to embrace in 2023 to remain competitive in today’s ever-changing healthcare marketplace. 9 Healthcare Marketing Trends 2023. Competition from Retail and Telehealth Disruptors Continues to Intensif y. Consumer-First Content is Essential.

article thumbnail

Inflationary Impact on Employer-Sponsored Health Coverage: Will a Recession be Different this Time?

PM360

A continued surge in inflation could potentially devastate healthcare providers, payers, and ultimately, patients. Through June 2022, average real weekly earnings are down 4.4% This suggests that inflation for consumers will continue to increase in 2022. in the first quarter of 2022, followed by a second decline of.6%

article thumbnail

Navigating the rapidly changing oncology treatment landscape: how digital tools can help

Impetus Digital

In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. Increased competition and evolving standard of care New competitors are entering the market at a rapid pace, and competition is intensifying. However, with rapid growth comes growing pains.

article thumbnail

9 Steps to Build Digital Healthcare Solutions that Meet Patient’s Growing Expectations

PM360

Patients now demand greater access to their health information, desire more communication with their healthcare providers, and seek personalized care tailored to their individual needs. Patients increasingly expect a seamless healthcare experience in which all their health information is integrated and easily accessible.